Inmunologist, BMRC Consortium researcher and Director for Coronovac Study for Chile, said that the collaboration that has happened within Chilean scientist sector "has been very positive and this is a unprecedented event in the science history".

Dr. Hernán González, BMRC Consortium researcher, indetified a frequent issue among its patients and start to investigate until he created a diagnosis technique with a huge potential in his area. Tha was the easy part. Building a medical technology company, valued at US$35 millions (and growing), it could be a little bit harder.

Alexis Kalergis comissioned 25.000 doses of immunizations against the metapneumovirus to the United Estates.

"Globally, there are 600,000 cases of thyroid cancer annually. However, there is not one test to predict the aggressiveness of this illness in order to choose more precise treatments according to the patient's profile. After the development of a thyroid cancer diagnostic test - known as Thyrioprint - it was logical to follow up with a second test that could predict with high accuracy the biological behavior of the tumor. Knowing how aggressive the cancer is can change the definitive treatment of the profile of the patient prior to surgery.”

Research Line / Diagnostics
Project:
Thyroid Cancer Prognosis Test

Human metapneumovirus is one of the most dangerous viruses in acute respiratory infections and currently has no specific treatment or vaccines to combat it.

Report on winners of the Avonni 2019 award.